TECTONIC THERAPEUTIC, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
TECTONIC THERAPEUTIC, INC. (TECX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 934.50 thousand shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2024-11-12
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 59.70K shares.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 874.80K shares, a 608.33% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 0.00 shares.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 123.50K shares, a 97.70% decline from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 5.37M shares, a 26.25% increase from fiscal 2021.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 4.25M shares, a 40.85% increase from fiscal 2020.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 3.02M shares, a 81.04% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2024-09-30 | 59.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 934.50K shares derived: sum of 2 quarters · filed 2024-11-12 | 934.50K shares 10-Q · filed 2024-11-12 | 934.50K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 874.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 874.80K shares 10-Q · filed 2024-08-14 | 874.80K shares derived: sum of 3 quarters · filed 2024-08-14 | 874.80K shares derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | 0.00 shares derived: sum of 2 quarters · filed 2024-05-09 | 0.00 shares derived: sum of 3 quarters · filed 2024-05-09 | 123.50K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-14 | 123.50K shares derived: sum of 3 quarters · filed 2024-03-14 | 123.50K shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 123.50K shares derived: sum of 2 quarters · filed 2023-11-09 | 123.50K shares 10-Q · filed 2023-11-09 | 2.04M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 123.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 123.50K shares 10-Q · filed 2023-08-10 | 2.04M shares derived: sum of 3 quarters · filed 2023-08-10 | 2.04M shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-11 | 1.91M shares derived: sum of 2 quarters · filed 2023-05-11 | 1.91M shares derived: sum of 3 quarters · filed 2023-05-11 | 2.24M shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 1.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 1.91M shares derived: sum of 2 quarters · filed 2023-03-23 | 2.24M shares derived: sum of 3 quarters · filed 2023-03-23 | 5.37M shares 10-K · filed 2023-03-23 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 329.69K shares derived: sum of 2 quarters · filed 2022-11-08 | 3.46M shares 10-Q · filed 2022-11-08 | 3.79M shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 329.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 3.46M shares 10-Q · filed 2022-08-09 | 3.79M shares derived: sum of 3 quarters · filed 2022-08-09 | 3.97M shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 3.13M shares 10-Q · filed 2022-05-10 | 3.46M shares derived: sum of 2 quarters · filed 2022-05-10 | 3.64M shares derived: sum of 3 quarters · filed 2022-05-10 | 5.02M shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 336.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 510.00K shares derived: sum of 2 quarters · filed 2022-03-17 | 1.89M shares derived: sum of 3 quarters · filed 2022-03-17 | 4.25M shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 173.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 1.56M shares derived: sum of 2 quarters · filed 2021-11-04 | 3.92M shares 10-Q · filed 2021-11-04 | 4.45M shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 1.38M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 3.74M shares 10-Q · filed 2021-08-05 | 4.28M shares derived: sum of 3 quarters · filed 2021-08-05 | 4.51M shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 2.36M shares 10-Q · filed 2021-05-13 | 2.89M shares derived: sum of 2 quarters · filed 2021-05-13 | 3.13M shares derived: sum of 3 quarters · filed 2021-05-13 | 3.45M shares derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-12-31 | 534.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 769.95K shares derived: sum of 2 quarters · filed 2021-03-18 | 1.09M shares derived: sum of 3 quarters · filed 2021-03-18 | 3.02M shares 10-K · filed 2021-03-18 |
| 2020-09-30 | 235.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 552.70K shares derived: sum of 2 quarters · filed 2020-11-05 | 2.49M shares 10-Q · filed 2020-11-05 | 2.84M shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 317.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 2.25M shares 10-Q · filed 2020-08-06 | 2.60M shares derived: sum of 3 quarters · filed 2020-08-06 | 2.82M shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | 1.93M shares 10-Q · filed 2020-05-07 | 2.29M shares derived: sum of 2 quarters · filed 2020-05-07 | 2.51M shares derived: sum of 3 quarters · filed 2020-05-07 | 2.60M shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 352.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 573.09K shares derived: sum of 2 quarters · filed 2020-03-16 | 665.39K shares derived: sum of 3 quarters · filed 2020-03-16 | 1.67M shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 220.44K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 312.74K shares derived: sum of 2 quarters · filed 2019-11-07 | 1.32M shares 10-Q · filed 2019-11-07 | 1.67M shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 92.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 1.09M shares 10-Q · filed 2019-08-08 | 1.45M shares derived: sum of 3 quarters · filed 2019-08-08 | 1.54M shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | 1.00M shares 10-Q · filed 2019-05-13 | 1.36M shares derived: sum of 2 quarters · filed 2019-05-13 | 1.44M shares derived: sum of 3 quarters · filed 2019-05-13 | |
| 2018-12-31 | 354.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | 441.35K shares derived: sum of 2 quarters · filed 2019-03-25 | 1.28M shares 10-K · filed 2019-03-25 | |
| 2018-09-30 | 86.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 922.88K shares 10-Q · filed 2018-11-13 | ||
| 2018-06-30 | 836.18K shares 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |